Completed OBSERVATIONAL NCT06698432
SHR Predicts CMD in Patients with CCS (SHR-CMD-CCS)
Prognostic Implications of Stress Hyperglycemia Ratio for the Prognosis of Coronary Microvascular Dysfunction in Patients with Chronic Coronary Syndrome
Sponsor: Ya-Wei Xu
Conditions
Chronic Coronary Syndrome Coronary Microvascular Dysfunction (CMD) Index of Microvascular Resistance Prognosis
Interventions
caIMR
Updated 1 time since 2024 Last updated: Nov 19, 2024 Started: Jun 1, 2015 Primary completion: Jun 1, 2019 Completion: Jun 1, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06698432, this observational or N/A phase trial focuses on Chronic Coronary Syndrome and Coronary Microvascular Dysfunction (CMD) and remains completed. Sponsored by Ya-Wei Xu, it has been updated 1 time since 2015, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
1 version recorded Completed
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Ya-Wei Xu
Data source: Shanghai 10th People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.